Marilyn T. McGoldrick, Author at Thornton Law Firm

Study: Viagra And Revatio Users 84% More Likely To Develop Melanoma

by Marilyn T. McGoldrick | Jun 23, 2014 | Uncategorized

By Marilyn T. McGoldrick, Esq. Published on Jun 23, 2014 Recent reports show that the risk of developing melanoma, a potentially fatal skin cancer, is doubled for men who use Viagra® or Revatio®. Viagra and Revatio (sildenafil), manufactured and distributed by...

Bladder Cancer Linked To Diabetes Drug Actos

by Marilyn T. McGoldrick | Jun 10, 2014 | Uncategorized

Posted by Marilyn M. McGoldrick on Jun 10, 2014 1:13:17 PM Using the diabetes drug Actos for one year or more increases the risk of being diagnosed with bladder cancer by 39% according reports reviewed by the FDA in 2011. Even though the diabetes drug Actos (generic...

New Studies: Transvaginal Mesh Pain May Not End After Removal

by Marilyn T. McGoldrick | May 30, 2014 | Uncategorized

Posted by Marilyn J. McGoldrick on May 30, 2014 10:55:00 AM More medical evidence of the long-term consequences of the use of transvaginal mesh was presented during the American Urological Association’s annual meeting this month. While several studies...

Dialysis Solution NaturaLyte Liquid Bicarbonate Concentrate Recalled

by Marilyn T. McGoldrick | May 23, 2014 | Uncategorized

Posted by Marilyn McGoldrick on May 23, 2014 10:39:00 AM Fresenius Medical Care North America (FMCNA), a Massachusetts based company, will voluntarily recall 56 lots of NaturaLyte® Liquid Bicarbonate Concentrate, 6.4 liters (intended for use in hemodialysis machines)....

FDA Wants Transvaginal Mesh Classified As High Risk

by Marilyn T. McGoldrick | Apr 30, 2014 | Uncategorized

Posted by Marilyn McGoldrick on Apr 30, 2014 2:23:00 PM The Food and Drug Administration (FDA) has proposed that surgical mesh used vaginally for Pelvic Organ Prolapse (POP) be classified as a “high-risk” device and that manufacturers accordingly must...